An observational study in Vitamin D Deficiency, sponsored by First Affiliated Hospital of Zhejiang University. Enrolling by invitation at 2 sites in China. Per ClinicalTrials.gov, last updated 2026-10-08.
Sponsored by First Affiliated Hospital of Zhejiang University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Vitamin D Deficiency with a site in China — 3 open to participants now, 3 under way, none of them phase 3. Vitamin D Deficiency · China.
Among the 28 studies in Vitamin D Deficiency with a site in China, this one is the 2nd largest by planned enrollment of the 10 observational ones that give a count, is the only one that started in 2026, is one of 10 observational ones, and was the 28th registered.
800 studies on the registry are indexed under Vitamin D Deficiency; 60 are open to participants now.
Browse Vitamin D Deficiency studies →3 of the 28 studies in Vitamin D Deficiency with a site in China are open now. Recruiting first, the newest first:
Peking University First Hospital · Sites in China
Ages 19+
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Sites in China
Ages 1 days–5 yrs
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 37 Vitamin D Deficiency studies recruiting now, 16 (43%) set no upper age limit and 18 (49%) stop at 75 or younger; 10 take children under 18; 11 take healthy volunteers.
This study: all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 10,000 is above the median of 138 across 185 observational studies indexed under Vitamin D Deficiency.
Median enrollment 110 across the 18 interventional studies, 193 across the 10 observational. Of the 14 that completed or were terminated, 1 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 28 has an industry lead sponsor. The 10 most frequent:
First Affiliated Hospital of Zhejiang University is the lead sponsor of 264 studies on the registry; 145 are open to participants now.
First Affiliated Hospital of Zhejiang University has 1 study filed under Vitamin D Deficiency — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 28 studies in Vitamin D Deficiency with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Vitamin D deficiency is a global public health problem, with an estimated 1 billion people affected worldwide, and large-scale systematic data for Zhejiang Province remain scarce. This is a multicenter, retrospective cross-sectional study. The objectives are to: (1) assess the distribution of serum 25-hydroxyvitamin D [25(OH)D] levels across regions, seasons, and demographic groups in Zhejiang Province and estimate the prevalence of vitamin D deficiency (\<20 ng/mL) and insufficiency (20-29 ng/mL); (2) identify and quantify key determinants of vitamin D status, including environmental exposures (ultraviolet radiation, green coverage), lifestyle (outdoor activity, sun protection), dietary vitamin D intake, and individual characteristics; and (3) provide scientific evidence for targeted intervention strategies, public health policy, and clinical guidelines in Zhejiang Province.
The study population comprises individuals who underwent serum 25-hydroxyvitamin D [25(OH)D] measurement at multiple hospitals in Zhejiang Province in 2025. The population includes healthy individuals undergoing routine health checkups as well as patients with various chronic diseases (including chronic kidney disease, diabetes, and autoimmune diseases), spanning all age groups.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients who completed serum 25(OH)D measurement at participating hospitals in Zhejiang Province in 2025.
Serum 25-hydroxyvitamin D [25(OH)D] concentration
Serum 25-hydroxyvitamin D \[25(OH)D\] concentration, expressed in ng/mL. Measured from existing clinical laboratory results at each participating hospital.
Time frame: Time frame: Baseline (testing in 2025).
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Dec 2027, 14 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
First Affiliated Hospital of Zhejiang University →